Case Study: Sanofi uncovers disproportionate respiratory burden with Evidation’s remotely administered SGRQ

A Evidation Case Study

Preview of the Sanofi Case Study

Sanofi uncovers respiratory burden in 1,888 patients with Evidation

Sanofi sought to understand the potential differences in health impairment across individuals with various respiratory conditions and demographic subgroups to identify unrecognized disease burden related to Type 2 inflammation.

Evidation addressed this by leveraging its virtual cohort of nearly 4 million individuals to connect with participants living with asthma, COPD, and/or nasal polyps. These participants completed a digitally administered St. George’s Respiratory Questionnaire (SGRQ). Evidation's analysis revealed a disproportionate impact on females and those with COPD, with findings showing these groups experienced significantly higher impairment scores. This real-world, digitally-captured insight aids in the development of improved management strategies for these patient subgroups.


View this case study…

Evidation

11 Case Studies